Northrop Grumman saw its stock decline by 13.5% this week despite reporting steady revenue growth and a record backlog. Investors are weighing the impact of fixed-price contract overruns and a cooling Iran conflict.
- 13.5% weekly share price decline
- Revenue increased 4% YoY to $9.9 billion
- Backlog reached record $96 billion
- B-21 bomber budget overruns under fixed-price contracts
- Geopolitical shift in Iran conflict weighing on defense sector
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.